Cancer Gene Therapy
Encapsulated Suicide Therapy Makes Phase II Pancreatic Cancer Trial
Published in Gene Therapy Weekly, March 30th, 2000
"Pancreatic adenocarcinoma is difficult to treat and the prognosis is consequently poor," said Walter H. Gunzburg and colleagues from several universities and hospitals in Austria. "Gemcitabine was heralded as a breakthrough in the treatment of this cancer, but yet only extends life expectancy by a few months."
Gunzburg et al. presented data from their clinical trial at the conference Advances in Gene Technology: DNA, RNA, and Cancer, held in Miami, Florida, USA. The title of their presentation was "Local...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2000-03-30)
More Articles from Gene Therapy Weekly
- Cancer Gene Therapy
Combination p53 Gene Transfer/Cisplatin Therapy Reaches Patients - Cancer Gene Therapy
Ribozyme Inhibits Delta EGFR and Reverses Malignant Phenotype - Cancer Gene Therapy
Suicide Gene Therapy Trial for Pediatric Brain Tumors Is in Clinical Trials - Cardiovascular Gene Therapy
Congestive Heart Failure Might be Candidate for Gene Therapy - Cardiovascular Gene Therapy
Increased Gene Transfer with Modified Adenoviral Vectors - Cell Surface Engineering
New "Staudinger Ligation" Technique Labels Cells - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
